Antibiotic resistance just became more complex

Antibiotic resistance just became more complex
Stills from video. Staphylococci bacteria, which have been labelled with a green fluorescent protein, express a resistance gene for the antibiotic chloramphenicol. Black Streptococcus pneumoniae bacteria do not have the resistance gene. In a medium containing the antibiotic, the green cells begin to grow and divide whereas the non-resistant black cells don't. After a time, individual black cells begin to divide and they even outgrow their green companions. Credit: Sorgt et al. / University of Groningen

Bacteria that are susceptible to antibiotics can survive when enough resistant cells around them are expressing an antibiotic-deactivating factor. This new take on how the microbial context can compromise antibiotic therapy was published by a team of microbiologists from the University of Groningen microbiologists, together with colleagues from San Diego, in the journal PLOS Biology on 27 December.

The entire paper is summed up nicely in a short video clip of a crucial experiment in the study. We see Staphylococci bacteria, which have been labelled with a green fluorescent protein, expressing a gene for the antibiotic chloramphenicol. Next to them are black Streptococcus pneumoniae bacteria that do not have the resistance gene. In a medium containing the antibiotic, the green cells begin to grow and divide whereas the non-resistant black cells don't. After a time, individual black cells begin to divide and they even outgrow their green companions.

What is going on here? Microbiologist Robin Sorg, first author of the paper, explains: "The resistant cells take up the chloramphenicol and deactivate it. At a certain point, the concentration in the growth medium drops below a critical level and the non-resistant cells start growing." Something like this has been seen before. "Cells with resistance to penicillin can secrete beta-lactamase enzymes which break down the antibiotic. But in our case, the antibiotic is deactivated inside the ."

Time lapse

The discovery was made using time-lapse microscopy, and confirmed with computational modelling and a mouse pneumonia model. "In the mice, we observed that susceptible Streptococcus pneumoniae bacteria survive the chloramphenicol treatment when the animals are co-infected with resistant bacteria." Furthermore, the results ruled out a transfer of the resistance gene. The data is in line with anecdotal evidence from the clinic, where antibiotic-susceptible bacteria are sometimes cultured from patients who were unsuccessfully treated with antibiotics. Sorg: "This always puzzled physicians. Our work might provide one possible explanation."

We see Staphylococci bacteria, which have been labelled with a green fluorescent protein, expressing a resistance gene for the antibiotic chloramphenicol. Next to them are black Streptococcus pneumoniae bacteria that do not have the resistance gene. In a medium containing the antibiotic, the green cells begin to grow and divide whereas the non-resistant black cells don't. After a time, individual black cells begin to divide and they even outgrow their green companions. Credit: Sorg et al. / University of Groningen

So susceptible can survive longer when are present, and in the end even outcompete them. What does this mean for the spread of ? "It is complicated", Sorg says. "We know that antibiotic usage results in selection for resistance. However, we do not fully understand the processes, nor why antibiotic resistance can develop so fast. Single cell studies like ours help to fill in some of these details."

Metabolism

One thing that should be noted is that the susceptible cells in the experiment stop growing, but don't die. "Many antibiotic-induced killing mechanisms rely on dividing cells, or at least on cells with an active metabolism." What doesn't kill the will perhaps not make them stronger, but certainly gives them time to pick up from their environment.

This knowledge can inform doctors when treating a patient with antibiotics. "We know that we should use these drugs with discretion, but we may need to be even more careful than we thought." Sorg sketches a personalized-medicine approach, in which the non-pathogenic microbes present in a patient are checked for resistance genes. "That would increase the risk of a transfer to pathogens."

To prevent the occurrence of resistance in non-pathogenic microorganisms, it is of course important to use antibiotics as sparingly as possible. And perhaps one day, when our understanding of the mechanisms responsible for the spread of antibiotic resistance is more complete, we may find a way to stop it.


Explore further

Antibiotic resistance—it's a social thing

More information: Robin A. Sorg, Leo Lin, G. Sander van Doorn, Moritz Sorg, Joshua Olson, Victor Nizet, and Jan-Willem Veening: Collective Resistance in Microbial Communities by Intracellular Antibiotic Deactivation. PLOS Biology, 27 December 2016. DOI: 10.1371/journal.pbio.2000631
Journal information: PLoS Biology

Citation: Antibiotic resistance just became more complex (2016, December 27) retrieved 19 May 2019 from https://phys.org/news/2016-12-antibiotic-resistance-complex.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3687 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more